$2.06
arrow_drop_down0.48%Key Stats | |
---|---|
Open | $2.05 |
Prev. Close | $2.07 |
EPS | -1.32 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $195.18M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.03 | 2.06 |
52 Week Range | 1.50 | 8.33 |
Ratios | |
---|---|
EPS | -1.32 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82%
Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%
By 2034, CAR-T Cell Therapy Market Set to Soar USD 8.7 Billion, at 1.80% CAGR: Prophecy Market Insights
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Expert Ratings For Caribou Biosciences